Royalty Payments for Products. (a) Royalty Rates for Royalties Payable by Sanofi for Net Sales outside the United States. Subject to the other terms of this Section 9.6, during the Royalty Term, Sanofi shall make quarterly royalty payments to MyoKardia on aggregate Net Sales of each Product sold outside the United States during a Calendar Year at the applicable royalty rates as set forth below. Aggregate Net Sales of each Product outside the United States during a Calendar Year Royalty Rate Portion of aggregate Net Sales of each Product outside the United States during a Calendar Year less than or equal to [***] Dollars ($[***]) [***] % Portion of aggregate Net Sales of each Product outside the United States during a Calendar Year greater than [***] Dollars ($[***]) and less than or equal to [***] Dollars ($[***]) [***] % Portion of aggregate Net Sales of each Product outside the United States during a Calendar Year greater than [***] Dollars ($[***]) [***] %
Appears in 2 contracts
Samples: License and Collaboration Agreement (MyoKardia Inc), License and Collaboration Agreement (MyoKardia Inc)
Royalty Payments for Products. (a) Royalty Rates for Royalties Payable by Sanofi for on Net Sales outside the United States. Subject to the other terms of this Section 9.69.3, during the Royalty Term, Sanofi shall make quarterly royalty payments to MyoKardia RevMed on aggregate Net Sales of each Product sold outside the United States during a Calendar Year at the applicable royalty rates as set forth below. For clarity, royalties shall only be payable once on any sale of Product under this Agreement. Aggregate Net Sales of each Product outside the United States during a Calendar Year Royalty Rate Portion of aggregate Net Sales of each Product outside the United States during a Calendar Year less than or equal to $[***] Dollars ($[[ ***]) [***] % Portion of aggregate Net Sales of each Product outside the United States during a Calendar Year greater than $[***] Dollars ($[***]) and less than or equal to $[***] Dollars ($[[ ***]) [***] % Portion of aggregate Net Sales of each Product outside the United States during a Calendar Year greater than $[***] Dollars (and less than $[***] [ ***]) % Portion of aggregate Net Sales of each Product outside the United States during a Calendar Year greater than $[***] [ ***]%
Appears in 2 contracts
Samples: , Development and Commercialization Agreement (Revolution Medicines, Inc.), , Development and Commercialization Agreement (Revolution Medicines, Inc.)